Telix presents dosimetry data for prostate cancer drug candidate

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. GOOGL
6. APGE
7. DFTX
8. MU
9. IBM
10. HOOD

Go back to Telix presents dosimetry data for prostate cancer drug candidate
TRANS-LUX CORPORATION (NASDAQ: TLX) Delayed: 10.00 -0.09 (0.89%)
Previous Close $10.09    52 Week High $2.18 
Open $10.47    52 Week Low $0.30 
Day High $10.47    P/E N/A 
Day Low $10.00    EPS $-3.32 
Volume 140,828